Biosante Pharmaceuticals Inc. (NASDAQ:BPAX)
Industry: Healthcare

Listed 4 Consecutive Market Days. On List as of 01/25/2012 Through 01/31/2012

BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of various products for female sexual health and oncology. It provides LibiGel, a transdermal testosterone gel that is in Phase III clinical development for the treatment of female sexual dysfunction; and male testosterone gel for the treatment of hypogonadism in men, which is licensed to Teva Pharmaceuticals USA, Inc. The company also offers various cancer vaccines, which are in Phase I and Phase II clinical trials for the treatment of melanoma, leukemia, pancreatic, breast, and prostate cancer; The Pill-Plus, which is in Phase II clinical trials is a combination of estrogens, progestogens, and androgens to prevent testosterone deficiency; and Elestrin, a food and drug administration approved product for the treatment of hot flashes associated with menopause. BioSante Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Lincolnshire, Illinois.

Current Quote*
Last: $Unk
Change: -1.080
Book: $4.200
Volume: Unk

As Of: 08/18 13:31 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol BPAX

  • No BuyIns.Net Alerts Available for BPAX

Graphs for BPAX

3 Month Graph

6 Month Graph

1 Year Graph